ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $133,000 | -80.1% | 3,300 | -71.6% | 0.03% | -77.0% |
| Q2 2015 | $668,000 | -64.7% | 11,600 | -60.9% | 0.12% | -66.1% |
| Q1 2015 | $1,891,000 | +2.8% | 29,700 | -0.3% | 0.36% | +1.1% |
| Q4 2014 | $1,840,000 | +58.9% | 29,800 | -0.1% | 0.36% | +171.8% |
| Q3 2014 | $1,158,000 | +12.4% | 29,823 | -0.3% | 0.13% | +17.0% |
| Q2 2014 | $1,030,000 | -6.9% | 29,919 | +16.9% | 0.11% | -11.1% |
| Q1 2014 | $1,106,000 | +8.1% | 25,600 | -0.4% | 0.13% | +2.4% |
| Q4 2013 | $1,023,000 | +6.1% | 25,700 | 0.0% | 0.12% | -0.8% |
| Q3 2013 | $964,000 | +39.7% | 25,700 | 0.0% | 0.12% | +30.5% |
| Q2 2013 | $690,000 | – | 25,700 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |